Anthocyanins suppress the cleavable complex formation by irinotecan and diminish its DNA-strand-breaking activity in the colon of wistar rats

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 835-840

  Esselen, Melanie ^a   Barth, Stephan W ^b   Winkler, Swantje ^c   Baechler, Simone ^c   Briviba, Karlis ^b   Watzl, Bernhard ^b   Skrbek, Susanne ^b   Marko, Doris ^c  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^b FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; CYANIDIN 3 GLUCOSIDE; DNA TOPOISOMERASE; IRINOTECAN;

ARTICLE; COMET ASSAY; COMPLEX FORMATION; DNA DAMAGE; DNA DETERMINATION; DNA PROTEIN COMPLEX; DNA STRAND BREAKAGE; DRUG EFFECT; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTHOCYANINS; CAMPTOTHECIN; COLON; DNA BREAKS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; FRUIT; GLUCOSIDES; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84875926405     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs398     Document Type: Article

References (56)

1. Cooke,D. et al. (2005) Anthocyans from fruits and vegetables-does bright colour signal cancer chemopreventive activity? Eur. J. Cancer, 41, 1931-1940.
2. Liu,R.H. (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr., 78, 517-520.
3. Duthie,G.G. et al. (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr. Res. Rev., 13, 79-106.
4. Hertog,M.G. et al. (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer, 20, 21-29.
5. Montonen,J. et al. (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care, 27, 362-366.
6. Clifford,M.N. (2000) Anthocyanins: nature, occurrence and dietary burden. J. Sci. Food Agric., 80, 1063-1072.
7. Wu,X. et al. (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem., 54, 4069-4075.
8. Duthie,S.J. et al. (2005) DNA stability and lipid peroxidation in vitamin E deficient rats in vivo and colon cells in vitro: modulation by the dietary anthocyanin, cyanidin-3-glycoside. Eur. J. Nutr., 44, 195-203.
9. Olsson,M. et al. (2004) Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J. Agric. Food Chem., 52, 7264-7271.
10. Cooke,D. et al. (2006) Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis-relationship with tissue anthocyanin levels. Int. J. Cancer, 119, 2213-2220.
11. Kang,S.Y. et al. (2003) Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett., 194, 13-19.
12. Chen,P.N. et al. (2005) Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr. Cancer, 53, 232-243.
13. Ding,M. et al. (2006) Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J. Biol. Chem., 281, 17359-17368.
14. Lamy,S. et al. (2006) Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis, 27, 989-996.
15. Afaq,F. et al. (2008) Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables. Int. J. Cancer, 123, 1508-1515.
16. Teller,N. et al. (2009) Suppression of the kinase activity of receptor tyrosine kinases by anthocyanin-rich mixtures extracted from bilberries and grapes. J. Agric. Food Chem., 57, 3094-3101.
17. Lee,S.H. et al. (2009) Induction of apoptosis in human leukemia U937 cells by anthocyanins through down-regulation of Bcl-2 and activation of caspases. Int. J. Oncol., 34, 1077-1083.
18. Hafeez,B.B. et al. (2008) A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res., 68, 8564-8572.
19. Seeram,N.P. et al. (2006) Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J. Agric. Food Chem., 54, 9329-9339.
20. Jo,J.Y. et al. (2006) Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols. J. Agric. Food Chem., 54, 2083-2097.
21. Habermeyer,M. et al. (2005) Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity. Chem. Res. Toxicol., 18, 1395-1404.
22. Esselen,M. et al. (2009) Delphinidin modulates the DNA damaging properties of topoisomerase II poisons. Chem. Res. Toxicol., 30, 554-564.
23. Esselen,M. et al. (2011) Anthocyanin-rich extracts suppress the DNAdamaging effects of topoisomerase poisons in human colon cancer cells. Mol. Nutr. Food Res., 55, 143-153.
24. Esselen,M. et al. (2011) Anthocyanin-rich blackberry extract suppresses the DNA-damaging properties of topoisomerase I and II poisons in colon carcinoma cells. J. Agric. Food Chem., 59, 6966-6973.
25. Mathijssen,R.H. et al. (2002) Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. Curr. Cancer Drug Targets, 2, 103-123.
26. Hsiang,Y.H. et al. (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res., 48, 1722-1726.
27. Champoux,J.J. (2001) DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem., 70, 369-413.
28. Bandele,O.J. et al. (2008) (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases. Chem. Res. Toxicol., 21, 936-943.
29. Bandele,O.J. et al. (2007) Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry, 46, 6097-6108.
30. Auzanneau,C. et al. (2012) The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II. Mol. Pharmacol., 82, 134-141.
31. Kalfalah,F.M. et al. (2011) Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence. Mol. Nutr. Food Res., 55, 5127-5142.
32. Ross,J.A. et al. (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control, 7, 581-590.
33. Lanoue,L. et al. (2010) Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity. Exp. Biol. Med., 235, 77-89.
34. Barth,S.W. et al. (2010) In vivo bioassay to detect irinotecan-stabilized DNA/topoisomerase I complexes in rats. Biotechnol. J., 5, 321-327.
35. El Mohsen,M.A. et al. (2006). Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br. J. Nutr., 95, 51-58.
36. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. (2005) Guidance for industry-estimating the maximum safe starting dose in initial clinical trails for therapeutics in adult healthy volunteers. http://www.fda.gov/ohrms/dockets/98fr/02d-0492-gdl0002.pdf (8 January 2013, date last accessed).
37. Wollowski,I. et al. (1999) Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J. Nutr., 129, 77-82.
38. Barth,S.W. et al. (2005) Cloudy apple juice decreases DNA damage, hyperproliferation and aberrant crypt foci development in the distal colon of DMH-initiated rats. Carcinogenesis, 26, 1414-1421.
39. Yang,X. et al. (2005) Novel agents that potentially inhibit irinotecaninduced diarrhea. Curr. Med. Chem., 12, 1343-1358.
40. Cunningham,D. et al. (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet, 352, 1413-1418.
41. Rothenberg,M.L. et al. (2001) Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Ann. Oncol., 12, 1631-1641.
42. He,J. et al. (2009) Stability of black raspberry anthocyanins in the digestive tract lumen and transport efficiency into gastric and small intestinal tissues in the rat. J. Agric. Food Chem., 57, 3141-3148.
43. Borges,G. et al. (2007) The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol. Nutr. Food Res., 51, 714-725.
44. Miyazawa,T. et al. (1999) Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J. Agric. Food Chem., 47, 1083-1091.
45. Tsuda,T. et al. (1999) Absorption and metabolism of cyanidin 3-O-beta-Dglucoside in rats. FEBS Lett., 449, 179-182.
46. Felgines,C. et al. (2002) Blackberry anthocyanins are slightly bioavailable in rats. J. Nutr., 132, 1249-1253.
47. Talavera,S. et al. (2003) Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. J. Nutr., 133, 4178-4182.
48. Ichiyanagi,T. et al. (2005) Extended glucuronidation is another major path of cyanidin 3-O-[beta]-D-glucopyranoside metabolism in rats. J. Agric. Food Chem., 53, 7312-7319.
49. Wu,X. et al. (2002) Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J. Nutr., 132, 1865-1871.
50. Vitaglione,P. et al. (2007) Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr., 137, 2043-2048.
51. Williamson,G. et al. (2010) Colonic metabolites of berry polyphenols: the missing link to biological activity? Br. J. Nutr., 104, 48-66.
52. Hassimotto,N.M. et al. (2008) Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr. Res., 28, 198-207.
53. Wang,L. et al. (2002) Catalytic inhibitors of topoisomerase II are DNAdamaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ. Mol. Mutagen., 39, 348-356.
54. Wang,L. et al. (2007) Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Mutat. Res., 616, 70-82.
55. Lin,L.C. et al. (2008) Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38. Chem. Biol. Interact., 174, 177-182.
56. Mirkov,S. et al. (2007) Effects of green tea compounds on irinotecan metabolism. Drug Metab. Dispos., 35, 228-233.